6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid

C100H104N10O20 — CID 157121318

IUPAC6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid
SMILESCCc1c(-c2ccc3c(c2)c(C)c(C)n3C)[nH]c(=O)c(C(=O)O)c1O.CCc1c(-c2ccc3c(c2)c2c(n3C)CCCC2)[nH]c(=O)c(C(=O)O)c1O.CCc1c(-c2ccc3c(ccn3CC3OCCO3)c2)[nH]c(=O)c(C(=O)O)c1O.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)c(C)c(C)n2C.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)c1c(n2C)CCCC1
InChIInChI=1S/C21H22N2O4.C21H22N2O3.C20H20N2O6.C19H20N2O4.C19H20N2O3/c1-3-12-18(22-20(25)17(19(12)24)21(26)27)11-8-9-16-14(10-11)13-6-4-5-7-15(13)23(16)2;1-3-12-10-16(21(25)26)20(24)22-19(12)13-8-9-18-15(11-13)14-6-4-5-7-17(14)23(18)2;1-2-13-17(21-19(24)16(18(13)23)20(25)26)12-3-4-14-11(9-12)5-6-22(14)10-15-27-7-8-28-15;1-5-12-16(20-18(23)15(17(12)22)19(24)25)11-6-7-14-13(8-11)9(2)10(3)21(14)4;1-5-12-8-15(19(23)24)18(22)20-17(12)13-6-7-16-14(9-13)10(2)11(3)21(16)4/h8-10H,3-7H2,1-2H3,(H,26,27)(H2,22,24,25);8-11H,3-7H2,1-2H3,(H,22,24)(H,25,26);3-6,9,15H,2,7-8,10H2,1H3,(H,25,26)(H2,21,23,24);6-8H,5H2,1-4H3,(H,24,25)(H2,20,22,23);6-9H,5H2,1-4H3,(H,20,22)(H,23,24)
InChIKeyAHZSRWQXKZLMOG-UHFFFAOYSA-N
MW1765.98 g/mol
LogP15.91
Rot. Bonds17

About 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid

6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid (PubChem CID 157121318) has the molecular formula C100H104N10O20 and a molecular weight of 1765.98 g/mol. Its IUPAC name is 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid.

Molecular Properties

Compound Name6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid
PubChem CID157121318
Molecular FormulaC100H104N10O20
Molecular Weight1765.98 g/mol
Exact Mass1764.74
IUPAC Name6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid
SMILESCCc1c(-c2ccc3c(c2)c(C)c(C)n3C)[nH]c(=O)c(C(=O)O)c1O.CCc1c(-c2ccc3c(c2)c2c(n3C)CCCC2)[nH]c(=O)c(C(=O)O)c1O.CCc1c(-c2ccc3c(ccn3CC3OCCO3)c2)[nH]c(=O)c(C(=O)O)c1O.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)c(C)c(C)n2C.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)c1c(n2C)CCCC1
InChIInChI=1S/C21H22N2O4.C21H22N2O3.C20H20N2O6.C19H20N2O4.C19H20N2O3/c1-3-12-18(22-20(25)17(19(12)24)21(26)27)11-8-9-16-14(10-11)13-6-4-5-7-15(13)23(16)2;1-3-12-10-16(21(25)26)20(24)22-19(12)13-8-9-18-15(11-13)14-6-4-5-7-17(14)23(18)2;1-2-13-17(21-19(24)16(18(13)23)20(25)26)12-3-4-14-11(9-12)5-6-22(14)10-15-27-7-8-28-15;1-5-12-16(20-18(23)15(17(12)22)19(24)25)11-6-7-14-13(8-11)9(2)10(3)21(14)4;1-5-12-8-15(19(23)24)18(22)20-17(12)13-6-7-16-14(9-13)10(2)11(3)21(16)4/h8-10H,3-7H2,1-2H3,(H,26,27)(H2,22,24,25);8-11H,3-7H2,1-2H3,(H,22,24)(H,25,26);3-6,9,15H,2,7-8,10H2,1H3,(H,25,26)(H2,21,23,24);6-8H,5H2,1-4H3,(H,24,25)(H2,20,22,23);6-9H,5H2,1-4H3,(H,20,22)(H,23,24)
InChIKeyAHZSRWQXKZLMOG-UHFFFAOYSA-N
XLogP15.91
TPSA454.60 Ų
H-Bond Donors13
H-Bond Acceptors20
Rotatable Bonds17
Heavy Atoms130
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001765.98
LogP ≤ 515.91
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Analyze 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid?
The IUPAC name of 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid (CID 157121318) is 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid.
What is the SMILES notation for 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid?
The canonical SMILES for 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid is CCc1c(-c2ccc3c(c2)c(C)c(C)n3C)[nH]c(=O)c(C(=O)O)c1O.CCc1c(-c2ccc3c(c2)c2c(n3C)CCCC2)[nH]c(=O)c(C(=O)O)c1O.CCc1c(-c2ccc3c(ccn3CC3OCCO3)c2)[nH]c(=O)c(C(=O)O)c1O.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)c(C)c(C)n2C.CCc1cc(C(=O)O)c(=O)[nH]c1-c1ccc2c(c1)c1c(n2C)CCCC1.
What is the InChIKey of 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid?
The InChIKey is AHZSRWQXKZLMOG-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H22N2O4.C21H22N2O3.C20H20N2O6.C19H20N2O4.C19H20N2O3/c1-3-12-18(22-20(25)17(19(12)24)21(26)27)11-8-9-16-14(10-11)13-6-4-5-7-15(13)23(16)2;1-3-12-10-16(21(25)26)20(24)22-19(12)13-8-9-18-15(11-13)14-6-4-5-7-17(14)23(18)2;1-2-13-17(21-19(24)16(18(13)23)20(25)26)12-3-4-14-11(9-12)5-6-22(14)10-15-27-7-8-28-15;1-5-12-16(20-18(23)15(17(12)22)19(24)25)11-6-7-14-13(8-11)9(2)10(3)21(14)4;1-5-12-8-15(19(23)24)18(22)20-17(12)13-6-7-16-14(9-13)10(2)11(3)21(16)4/h8-10H,3-7H2,1-2H3,(H,26,27)(H2,22,24,25);8-11H,3-7H2,1-2H3,(H,22,24)(H,25,26);3-6,9,15H,2,7-8,10H2,1H3,(H,25,26)(H2,21,23,24);6-8H,5H2,1-4H3,(H,24,25)(H2,20,22,23);6-9H,5H2,1-4H3,(H,20,22)(H,23,24).
What are the key properties of 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid?
6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid has a molecular weight of 1765.98 g/mol, XLogP of 15.91, 17 rotatable bonds, 13 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[1-(1,3-dioxolan-2-ylmethyl)indol-5-yl]-5-ethyl-4-hydroxy-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-4-hydroxy-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid;5-ethyl-6-(9-methyl-5,6,7,8-tetrahydrocarbazol-3-yl)-2-oxo-1H-pyridine-3-carboxylic acid;5-ethyl-2-oxo-6-(1,2,3-trimethylindol-5-yl)-1H-pyridine-3-carboxylic acid is sourced from PubChem (CID 157121318), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).